Evidence map›Paper›PMID 28963981›Full record

ReviewDNA repair2017

Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis.

Elena Pires, Patrick Sung, Claudia Wiese

Abstract readReview
In one paragraph

Review in DNA repair, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis.The Journal of international medical research · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. RAD51AP1 is a versatile RAD51 modulator.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Phosphoregulation of RAD51AP1 function in homology-directed repair.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. International journal of general medicine · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena PiresDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Patrick SungDepartment of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: patrick.sung@yale.edu.
Claudia WieseDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA. Electronic address: claudia.wiese@colostate.edu.

Funding

Mechanistic Dissection of the Fanconi Anemia Pathway of DNA Damage Response and RR01CA168635 · NCI · YALE UNIVERSITY · PI Gary M Kupfer, Patrick Sung · 2013 to 2026
$5.8M
NUCKS, a novel double-strand break repair gene, implicated in cancer biologyR01ES021454 · NIEHS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WIESE, CLAUDIA · 2012 to 2016
$1.9M
Genome Maintenance via the BRCA-PALB2 Tumor Suppressor NetworkR01CA220123 · NCI · YALE UNIVERSITY · PI SUNG, PATRICK · 2017 to 2019
$1.2M
Veterinary Pre-Doctoral Research Scholars ProgramT32OD012201 · OD · COLORADO STATE UNIVERSITY · PI VANDEWOUDE, SUE · 2013 to 2019
$795k
Define the role of NUCKS1 in homologous recombination DNA repair and cancer biologyR56ES021454 · NIEHS · COLORADO STATE UNIVERSITY · PI WIESE, CLAUDIA · 2019 to 2019
$225k
NCI NIH HHS R01 CA168635NCI NIH HHS R01 CA220123NIEHS NIH HHS R01 ES021454NIEHS NIH HHS R56 ES021454NIH HHS T32 OD012201
6 · The paper itself

Abstract

Homologous recombination (HR) serves to repair DNA double-strand breaks and damaged replication forks and is essential for maintaining genome stability and tumor suppression. HR capacity also determines the efficacy of anticancer therapy. Hence, there is an urgent need to better understand all HR proteins and sub-pathways. An emerging protein that is critical for RAD51-mediated HR is RAD51-associated protein 1 (RAD51AP1). Although much has been learned about its biochemical attributes, the precise molecular role of RAD51AP1 in the HR reaction is not yet fully understood. The available literature also suggests that RAD51AP1 expression may be relevant for cancer development and progression. Here, we review the efforts that led to the discovery of RAD51AP1 and elaborate on our current understanding of its biochemical profile and biological function. We also discuss how RAD51AP1 may help to promote cancer development and why it could potentially represent a promising new target for therapeutic intervention.

Indexed as

Recombinational DNA RepairAnimalsCarcinogenesisCarrier ProteinsDNA-Binding ProteinsHumansMiceNuclear ProteinsRNA-Binding ProteinsCarrier ProteinsDNA-Binding ProteinsNuclear ProteinsRAD51AP1 protein, humanRad51ap1 protein, mouseRNA-Binding ProteinsCancerCancer therapyDNA double-strand breaksDNA repairGenome stabilityHomologous recombinationRAD51AP1Replication

Identifiers

PMID28963981
PMCPMC5643253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.